122
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of Chronic Obstructive Pulmonary Disease with Risk of Psychiatric Disorders: A Two-Sample Mendelian Randomization Study

, &
Pages 343-351 | Received 01 Oct 2023, Accepted 14 Jan 2024, Published online: 31 Jan 2024

References

  • Guo P, Li R, Piao TH, Wang CL, Wu XL, Cai HY. Pathological mechanism and targeted drugs of COPD. Int J Chron Obstruct Pulmon Dis. 2022;17:1565–1575. doi:10.2147/COPD.S366126
  • Tashkin DP, Goodin T, Bowling A, et al. Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies. Respir Res. 2019;20(1):135. doi:10.1186/s12931-019-1112-0
  • Burkow TM, Vognild LK, Johnsen E, Bratvold A, Risberg MJ. Promoting exercise training and physical activity in daily life: a feasibility study of a virtual group intervention for behaviour change in COPD. BMC Med Inform Decis Mak. 2018;18(1):136. doi:10.1186/s12911-018-0721-8
  • van Boven JF, van Raaij JJ, van der Galien R, et al. Impact of multiple-dose versus single-dose inhaler devices on COPD patients’ persistence with long-acting beta(2)-agonists: a dispensing database analysis. NPJ Prim Care Respir Med. 2014;24:14069. doi:10.1038/npjpcrm.2014.69
  • Ge H, Liu X, Gu W, et al. Distribution of COPD comorbidities and creation of acute exacerbation risk score: results from SCICP. J Inflamm Res. 2021;14:3335–3348. doi:10.2147/JIR.S315600
  • Bel EH. Obesity and asthma control: do gender, age, and ethnicity really matter? Am J Respir Crit Care Med. 2013;187(7):667–668. doi:10.1164/rccm.201302-0333ed
  • Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23(133):345–349. doi:10.1183/09059180.00007813
  • Pollok J, van Agteren JEM, Carson KV, Esterman AJ, Smith BJ, Licinio J. Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2019;3(3):CD012347. doi:10.1002/14651858.Cd012347
  • Bonnevie T, Medrinal C, Combret Y, et al. Mid-term effects of pulmonary rehabilitation on cognitive function in people with severe chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:1111–1121. doi:10.2147/COPD.S2494093
  • Su VY, Hu LY, Yeh CM, et al. Chronic obstructive pulmonary disease associated with increased risk of bipolar disorder. Chron Respir Dis. 2017;14(2):151–160. doi:10.1177/1479972316680846
  • Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601. doi:10.1136/bmj.k601
  • Smith GD, Lawlor DA, Harbord R, Timpson N, Day I, Ebrahim S. Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med. 2007;4(12):e352. doi:10.1371/journal.pmed.0040352
  • Pingault JB, O’Reilly PF, Schoeler T, Ploubidis GB, Rijsdijk F, Dudbridge F. Using genetic data to strengthen causal inference in observational research. Nat Rev Genet. 2018;19(9):566–580. doi:10.1038/s41576-018-0020-3
  • Bellenguez C, Kucukali F, Jansen IE, et al. New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat Genet. 2022;54(4):412–436. doi:10.1038/s41588-022-01024-z
  • Watson HJ, Yilmaz Z, Thornton LM, et al. Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa. Nat Genet. 2019;51(8):1207–1214. doi:10.1038/s41588-019-0439-2
  • Schoeler T, Speed D, Porcu E, Pirastu N, Pingault JB, Kutalik Z. Participation bias in the UK biobank distorts genetic associations and downstream analyses. Nat Hum Behav. 2023;7(7):1216–1227. doi:10.1038/s41562-023-01579-9
  • Demontis D, Walters GB, Athanasiadis G, et al. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nat Genet. 2023;55(2):198–208. doi:10.1038/s41588-022-01285-8
  • Stahl EA, Breen G, Forstner AJ, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet. 2019;51(5):793–803. doi:10.1038/s41588-019-0397-8
  • Howard DM, Adams MJ, Clarke TK, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2019;22(3):343–352. doi:10.1038/s41593-018-0326-7
  • Cross-Disorder Group of the Psychiatric Genomics Consortium. Electronic address pmhe, Cross-Disorder Group of the Psychiatric Genomics C. Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell. 2019;179(7):1469–1482 e11. doi:10.1016/j.cell.2019.11.020
  • International Obsessive Compulsive Disorder Foundation Genetics C, Studies OCDCGA. Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis. Mol Psychiatry. 2018;23(5):1181–1188. doi:10.1038/mp.2017.154
  • Nievergelt CM, Maihofer AX, Klengel T, et al. International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci. Nat Commun. 2019;10(1):4558. doi:10.1038/s41467-019-12576-w
  • Trubetskoy V, Pardinas AF, Qi T, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604(7906):502–508. doi:10.1038/s41586-022-04434-5
  • Christensen KS, Oernboel E, Nielsen MG, Bech P. Diagnosing depression in primary care: a rasch analysis of the major depression inventory. Scand J Prim Health Care. 2019;37(2):256–263. doi:10.1080/02813432.2019.1608039
  • Zalsman G, Shilton T. Adult ADHD: a new disease? Int J Psychiatry Clin Pract. 2016;20(2):70–76. doi:10.3109/13651501.2016.1149197
  • Abecasis GR, Auton A, Brooks LD, et al. An integrated map of genetic variation from 1092 human genomes. Nature. 2012;491(7422):56–65. doi:10.1038/nature11632
  • Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7. doi:10.1186/s13742-015-0047-8
  • Hemani G, Bowden J, Davey Smith G. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27(R2):R195–R208. doi:10.1093/hmg/ddy163
  • Zhu Z, Zhang F, Hu H, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48(5):481–487. doi:10.1038/ng.3538
  • Drago V, Babiloni C, Bartres-Faz D, et al. Disease tracking markers for Alzheimer’s disease at the prodromal (MCI) stage. J Alzheimers Dis. 2011;26(Suppl 3):159–199. doi:10.3233/JAD-2011-0043
  • Dodd JW. Lung disease as a determinant of cognitive decline and dementia. Alzheimers Res Ther. 2015;7(1):32. doi:10.1186/s13195-015-0116-3
  • Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185. doi:10.1183/09031936.00128008
  • Higbee D, Granell R, Walton E, Korologou-Linden R, Davey Smith G, Dodd J. Examining the possible causal relationship between lung function, COPD and Alzheimer’s disease: a Mendelian randomisation study. BMJ Open Respir Res. 2021;8(1):e000759. doi:10.1136/bmjresp-2020-000759
  • Durazzo TC, Mattsson N, Weiner MW. Alzheimer’s disease neuroimaging i. smoking and increased Alzheimer’s disease risk: a review of potential mechanisms. Alzheimers Dement. 2014;10(3 Suppl):S122–S145. doi:10.1016/j.jalz.2014.04.009
  • Cataldo JK, Prochaska JJ, Glantz SA. Cigarette smoking is a risk factor for Alzheimer’s disease: an analysis controlling for tobacco industry affiliation. J Alzheimers Dis. 2010;19(2):465–480. doi:10.3233/JAD-2010-1240
  • Tyas SL, White LR, Petrovitch H, et al. Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study. Neurobiol Aging. 2003;24(4):589–596. doi:10.1016/s0197-4580(02)00156-2
  • Zeng H, Li T, He X, et al. Oxidative stress mediates the apoptosis and epigenetic modification of the Bcl-2 promoter via DNMT1 in a cigarette smoke-induced emphysema model. Respir Res. 2020;21(1):229. doi:10.1186/s12931-020-01495-w
  • Candela M, Costorella R, Stassaldi A, Maestrini V, Curradi G. Treatment of COPD: the simplicity is a resolved complexity. Multidiscip Respir Med. 2019;14:18. doi:10.1186/s40248-019-0181-8
  • Wadhwa R, Paudel KR, Mehta M, et al. Beyond the obvious: smoking and respiratory infection implications on Alzheimer’s disease. CNS Neurol Disord Drug Targets. 2020;19(9):698–708. doi:10.2174/1871527319999200817112427
  • Almeida OP, Garrido GJ, Alfonso H, et al. 24-month effect of smoking cessation on cognitive function and brain structure in later life. Neuroimage. 2011;55(4):1480–1489. doi:10.1016/j.neuroimage.2011.01.063
  • Campman CA, Sitskoorn MM. Better care for patients with COPD and cognitive impairment. Lancet Respir Med. 2013;1(7):504–506. doi:10.1016/S2213-2600(13)70163-2
  • Dodd JW, Novotny P, Sciurba FC, Benzo RP. Executive function, survival, and hospitalization in chronic obstructive pulmonary disease. a longitudinal analysis of the National Emphysema Treatment Trial (NETT). Ann Am Thorac Soc. 2015;12(10):1473–1481. doi:10.1513/AnnalsATS.201506-373OC
  • Hadanny A, Catalogna M, Yaniv S, et al. Hyperbaric oxygen therapy in children with post-concussion syndrome improves cognitive and behavioral function: a randomized controlled trial. Sci Rep. 2022;12(1):15233. doi:10.1038/s41598-022-19395-y
  • Connaughton M, Whelan R, O’Hanlon E, McGrath J. White matter microstructure in children and adolescents with ADHD. NeuroImage Clin. 2022;33:102957. doi:10.1016/j.nicl.2022.102957
  • Maremanda KP, Sundar IK, Rahman I. Role of inner mitochondrial protein OPA1 in mitochondrial dysfunction by tobacco smoking and in the pathogenesis of COPD. Redox Biol. 2021;45:102055. doi:10.1016/j.redox.2021.102055
  • Qin R, Liu Z, Zhou X, et al. Adherence and efficacy of smoking cessation treatment among patients with COPD in China. Int J Chron Obstruct Pulmon Dis. 2021;16:1203–1214. doi:10.2147/COPD.S301579
  • Fuemmeler BF, Kollins SH, McClernon FJ. Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood. J Pediatr Psychol. 2007;32(10):1203–1213. doi:10.1093/jpepsy/jsm051
  • Kollins SH, McClernon FJ, Fuemmeler BF. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch Gen Psychiatry. 2005;62(10):1142–1147. doi:10.1001/archpsyc.62.10.1142
  • Recio Iglesias J, Díez-Manglano J, López García F, Díaz Peromingo JA, Almagro P, Varela Aguilar JM. Management of the COPD patient with comorbidities: an experts recommendation document. Int J Chron Obstruct Pulmon Dis. 2020;15:1015–1037. doi:10.2147/copd.S242009
  • Fuentes-Alonso M, Lopez-Herranz M, Lopez-de-andres A, et al. Prevalence and determinants of mental health among COPD patients in a population-based sample in Spain. J Clin Med. 2021;10(13):2786. doi:10.3390/jcm10132786